Objective: To characterize women reported with AIDS and invasive cervi
cal cancer in the first year of the expanded AIDS surveillance case de
finition. Methods: Using chi(2) testing and logistic regression, we co
mpared women with invasive cervical cancer with those having other AID
S-defining illnesses. Results: Of the 16,794 women 13 years old or old
er and reported with AIDS in 1993, 217 (1.3%) had invasive cervical ca
ncer and 9113 (54.3%) had other opportunistic illnesses; the remaining
7464 (44.4%) had no opportunistic illnesses and were reported based o
n immunologic criteria. Women with invasive cervical cancer were more
likely to have had AIDS diagnosed before 1993 (73 and 56%, respectivel
y; P < .01), to be younger (median age 33 and 35 years; P < .001), to
be white (31 and 21%; P < .01), and to reside in the south (41 and 34%
; P < .05). Among women reported with CD4+ counts, the median value wa
s higher in 149 women with invasive cervical cancer than in the 5993 w
ith other opportunistic illnesses (153 and 50 cells/mu L, respectively
). Women with invasive cervical cancer were more likely to report inje
ction drug use (57 and 48%; P < .05). In multivariate analysis, Hispan
ic women were 0.6 times less likely to be reported with invasive cervi
cal cancer than were white women (P < .05). Among women infected throu
gh injecting drug use, black women were 0.5 times less likely to be re
ported with invasive cervical cancer (P < .001). Conclusion: Hispanic
and black women infected with HIV were less likely to be reported with
invasive cervical cancer, a finding that may be associated with inade
quate access to health care services. Women with invasive cervical can
cer were less severely immunosuppressed than women with other AIDS opp
ortunistic illnesses.